\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Digital, Industry & Space Horizon Europe Digital EuropeThe NCP Flanders team expands its services to also support interested parties and potential beneficiaries of the new framework programme Digital Europe (DIGITAL).
The programme will focus on digital key capacity areas, such as artificial intelligence, cybersecurity, advanced computing, data infrastructure, advanced digital skills, and ensuring a wide use of digital technologies and complement other programmes such as Horizon Europe. The work programmes 2021-2022 for DIGITAL are expected to be published in early October. More information on the programme can be found at https://ncpflanders.be/programmes/digital-europe-programme.
To receive email notifications for news on the DIGITAL programme, interested parties that are registered on the NCP Flanders website can now sign up this information by editing their profile and selecting DIGITAL under ‘Other EU Funding’.
If you have specific questions, do not hesitate to contact the NCP for the DIGITAL programme, Marie Timmermann (marie.timmermann@fwo.be).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
